Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Comparison of Intranasal Ketorolac and Intranasal Ketamine in Digital Nerve Block Pain
Tehran University of Medical Sciences
Ketamine Biomarker Validation
Soterix Medical
Efficacy and Safety of S-ketamine in Elderly Patients Undergoing Non-cardiac Surgery: a RCT（ESSENCE）
Chinese PLA General Hospital
Sedative and Analgesic Effects of Dexmedetomidine Versus Ketamine in Patients Undergoing Varicocelectomy Under Spinal Anaesthesia: A Prospective Randomized Comparative Trial
Assiut University
Ketamine for the Treatment of Refractory Status Epilepticus
Thomas Jefferson University
Ketamine Sedation in the ICU (KANINE) RCT
McMaster University
Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD
Queen's University
Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly Patients
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve Gastrectomy
IVO JURISIC
Effect of Different Drugs on Emergency Delirium in Preschool Age Patient
Zagazig University
Etomidate and Esketamine on Postoperative Pain After Tonsillectomy Undergoing Children
Anqing Municipal Hospital
Ketamine for Postherpetic Neuralgia With Depression
Huazhong University of Science and Technology
Ketamine and Lidocaine Infusion in Refractory Chronic Migraine
Assiut University
Evaluation of the Efficacy and Safety of Subcutaneous Ketamine in the Treatment of Depressive Episode With Suicidal Ideation and/or Behavior in Adolescents
Federal University of São Paulo
Effects of Intranasal Ketamine on Depression and Anxiety in Palliative Care Cancer Patients
University of Zurich
Feasibility of Closed-loop TCI Based on New EEG Baseline in the Presence of Low Dose of Esketamine
bo xu
Ketamine for Combined Depression and Alcohol Use Disorder
University Hospital of North Norway
Opioid Free Anesthesia Versus Opioid Based Anesthesia
Ain Shams University
Effects of Minimal-Flow Sevoflurane and Multimodal Analgesia in Head and Neck Cancer Surgery
National Taiwan University Hospital
Quelling of Excitotoxicity in Acute Stroke With Ketamine
Lower Merion Neurology Research Foundation
Ketamine Treatment for PTSD and MDD in TBI
Minneapolis Veterans Affairs Medical Center
Ketamine in Severe Traumatic Brain Injury
University of Texas Southwestern Medical Center
Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients
Hospital Italiano de Buenos Aires
Ketamine and Propofol NeuroImaging
Keith M Vogt
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine
University of Pennsylvania
Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
Mohsen Saidinejad
Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant Depression
Massachusetts General Hospital
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Salma Health, Inc.
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
University of Virginia
Prospective IR-led Sedation Feasibility
CAMC Health System
Ketamine for Veterans With Parkinson's Disease
VA Office of Research and Development
Ketamine for Opioid Use Disorder
University of Maryland, Baltimore
Pilot Study of RR-HNK in OCD
Carolyn Rodriguez
Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.
The Ketamine Research Foundation
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
Janssen Research & Development, LLC
Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression
VA Office of Research and Development
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
ACADIA Pharmaceuticals Inc.
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
Texas Tech University Health Sciences Center
Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant Depression
Hospital Universitari Vall d'Hebron Research Institute
Anesthesia Techniques, Neuroprotection and Surgical Field in FESS Under Controlled Hypotension
University General Hospital of Patras
Analgosedation With Ketamine, Nalbuphine, or Dexmedetomidine for Suture Removal in Children After Cleft Surgery
University Medical Centre Ljubljana
Pain Control Alternatives in Pediatric Patients With Distal Radius Fractures
State University of New York at Buffalo
Magnesium and Cramping
Corewell Health East
A Ketamine-assisted Group Therapy Intervention for Spanish-speaking Adults With Depression
Juliana Zambrano, MD, MPH
Ketamine Augmentation of ECT in Treatment-Resistant Depression
Università Vita-Salute San Raffaele
A Study of Ketamine Infusions to Treat Clinically-depressed ICU Patients
Mayo Clinic
Ketamine, SGB and Combination Treatment for TBI-associated Headache or PTSD
Northwestern University
Music as an Adjunct to Ketamine Therapy for Chronic Pain
McGill University
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.